Mindray Medical Announces Its Participation In Upcoming Investor Conferences
SHENZHEN, China, Dec. 28, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will participate in three investor conferences in January.
The first one, the 30th Annual J.P. Morgan Healthcare Conference, will be held January 9-11, 2012 at the Westin St. Francis Hotel in San Francisco. Mr. Alex Lung, Mindray's Chief Financial Officer, and Ms. May Li, Mindray's Deputy Chief Financial Officer, will attend the conference. Mr. Lung will present on Monday, January 9 at 4:30 pm PST and will meet with investors throughout the conference.
The second one, the UBS Greater China Conference 2012, will be held on January 10, 2012 at the Pudong Shangri-La Hotel in Shanghai. Mr. Minghe Cheng, Mindray's Chief Strategic Officer, and Ms. Cathy Gao, Mindray's Deputy Manager of Investor Relations, will attend the conference.
The last one, the DB Access China Conference 2012, will be held on January 11, 2012 at the Grand Hyatt Hotel in Beijing. Mr. Hang Xu, Mindray's Chairman & Co-CEO, and Ms. Cathy Gao, Mindray's Deputy Manager of Investor Relations, will attend the conference. Ms. Gao will present on Wednesday, January 11 at 11:00am HKT and will meet with investors throughout the conference.
About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com. For investor and media inquiries, please contact:Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
